Related Experiment Video

Updated: Jun 7, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Antiestrogens and their therapeutic applications in breast cancer and other diseases

Simak Ali1, Laki Buluwela, R Charles Coombes

  • 1Division of Cancer, Department of Surgery and Oncology, Imperial College London, Hammersmith Hospital, London W12 0NN, United Kingdom. simak.ali@imperial.ac.uk

Annual Review of Medicine
|November 9, 2010
PubMed

Insights

Antiestrogens, like tamoxifen, are crucial in treating breast cancer by blocking estrogen receptors. These drugs also offer benefits beyond cancer treatment, including bone density support and cardiovascular protection.

Area of Science:

  • Oncology
  • Endocrinology
  • Pharmacology

Background:

  • Estrogen plays a key role in breast cancer development.
  • Antiestrogens, such as tamoxifen, were developed to target estrogen receptors (ERs) in breast cancer cells.
  • Tamoxifen has significantly reduced breast cancer mortality over the last three decades.

Purpose of the Study:

  • To review the role of antiestrogens in breast cancer treatment and beyond.
  • To highlight the dual action of some antiestrogens as antiestrogenic in breast tissue and estrogen-like in other tissues.
  • To discuss the chemopreventive potential of antiestrogens in high-risk individuals.

Main Methods:

  • Literature review and synthesis of existing research on antiestrogens.
  • Analysis of clinical data regarding tamoxifen's efficacy and side effects.
  • Exploration of the pharmacological mechanisms of antiestrogens.

Main Results:

  • Antiestrogens, particularly tamoxifen, are effective in inhibiting ER-positive breast cancer.
  • Some antiestrogens exhibit beneficial effects on bone density and cardiovascular health.
  • Antiestrogens demonstrate efficacy in breast cancer chemoprevention.

Conclusions:

  • Antiestrogens are a well-established and vital class of drugs in breast cancer therapy.
  • The multifaceted actions of antiestrogens suggest broader therapeutic applications, including menopausal symptom management and cancer prevention.
  • Continued research and application of antiestrogens remain central to breast cancer treatment strategies.

More Related Videos

Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay06:07

Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay

Published on: June 7, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...